YorkBridge Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.8M | Buy |
5,084
+4,260
| +517% | +$2.35M | 0.71% | 39 |
|
|
2022
Q3 | $418K | Buy |
824
+19
| +2% | +$9.64K | 0.11% | 133 |
|
|
2022
Q2 | $437K | Buy |
805
+5
| +0.6% | +$2.71K | 0.11% | 136 |
|
|
2022
Q1 | $473K | Sell |
800
-34
| -4% | -$20.1K | 0.1% | 146 |
|
|
2021
Q4 | $556K | Hold |
834
| – | – | 0.12% | 129 |
|
|
2021
Q3 | $476K | Sell |
834
-11
| -1% | -$6.28K | 0.12% | 137 |
|
|
2021
Q2 | $426K | Hold |
845
| – | – | 0.11% | 144 |
|
|
2021
Q1 | $386K | Sell |
845
-22
| -3% | -$10.1K | 0.11% | 146 |
|
|
2020
Q4 | $404K | Sell |
867
-13
| -1% | -$6.06K | 0.14% | 122 |
|
|
2020
Q3 | $389K | Buy |
880
+3
| +0.3% | +$1.33K | 0.16% | 109 |
|
|
2020
Q2 | $318K | Hold |
877
| – | – | 0.15% | 126 |
|
|
2020
Q1 | $249K | Sell |
877
-78
| -8% | -$22.1K | 0.15% | 131 |
|
|
2019
Q4 | $310K | Sell |
955
-17
| -2% | -$5.52K | 0.14% | 142 |
|
|
2019
Q3 | $283K | Buy |
972
+17
| +2% | +$4.95K | 0.14% | 140 |
|
|
2019
Q2 | $280K | Sell |
955
-23
| -2% | -$6.74K | 0.12% | 148 |
|
|
2019
Q1 | $268K | Sell |
978
-170
| -15% | -$46.6K | 0.12% | 144 |
|
|
2018
Q4 | $257K | Sell |
1,148
-31
| -3% | -$6.94K | 0.14% | 135 |
|
|
2018
Q3 | $293K | Sell |
1,179
-30
| -2% | -$7.46K | 0.13% | 139 |
|
|
2018
Q2 | $250K | Hold |
1,209
| – | – | 0.11% | 154 |
|
|
2018
Q1 | $258K | Hold |
1,209
| – | – | 0.12% | 159 |
|
|
2017
Q4 | $252K | Sell |
1,209
-420
| -26% | -$87.5K | 0.12% | 158 |
|
|
2017
Q3 | $308K | Sell |
1,629
-8
| -0.5% | -$1.51K | 0.16% | 128 |
|
|
2017
Q2 | $286K | Sell |
1,637
-230
| -12% | -$40.2K | 0.15% | 131 |
|
|
2017
Q1 | $312K | Buy |
1,867
+595
| +47% | +$99.4K | 0.16% | 124 |
|
|
2016
Q4 | $183K | Buy |
+1,272
| New | +$183K | 0.11% | 161 |
|